In the last trading session, 2.09 million shares of the Charles River Laboratories International Inc (NYSE:CRL) were traded, and its beta was 1.45. Most recently the company’s share price was $115.41, and it changed around -$4.03 or -3.37% from the last close, which brings the market valuation of the company to $5.67B. CRL currently trades at a discount to its 52-week high of $254.15, offering almost -120.21% off that amount. The share price’s 52-week low was $91.86, which indicates that the current value has risen by an impressive 20.41% since then.
Charles River Laboratories International Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.90. If we narrow it down even further, the data shows that 1 out of 21 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 16 recommended CRL as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.
Charles River Laboratories International Inc (NYSE:CRL) trade information
Instantly CRL has showed a red trend with a performance of -3.37% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 121.81 on recent trading dayincreased the stock’s daily price by 5.25%. The company’s shares are currently down -37.48% year-to-date, but still down -1.60% over the last five days. On the other hand, Charles River Laboratories International Inc (NYSE:CRL) is -15.70% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $290, which translates to bulls needing to increase their stock price by 60.2% from its current value. Analyst projections state that CRL is forecast to be at a low of $151 and a high of $465.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -47.65%. Charles River Laboratories International Inc earnings are expected to increase by -9.75% in 2025, but the outlook is positive 2.55% per year for the next five years.
CRL Dividends
Charles River Laboratories International Inc’s next quarterly earnings report is expected to be released in June.
BLACKROCK INC., with 9.8699% or 5.09 million shares worth $1.05 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Jan 31, 2025 . The former held 2.0 shares worth $230.72 million, making up 4.07% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 1.6 shares worth around $184.48 million, which represents about 3.25% of the total shares outstanding.
